BioStem Technologies Adds Chief Revenue Officer to Executive Team
08 févr. 2018 17h00 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing...
BioStem Technologies, Inc. Announces the Engagement of Investment Banking Firm Young America Capital for 15 Million Dollar 506(c) Offering.
26 janv. 2018 09h45 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Jan. 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “Company”) announced today the engagement of investment banking firm Young America Capital...
BioStem Technologies Inc. Announces New Board Member, Dr. Jennie Sandqvist
24 janv. 2018 10h05 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Jan. 24, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “Company”) announced today that Dr. Jennie Sandqvist has joined the Company’s Board of...
BioStem Technologies Inc. Announces a Pre-Clinical Study of BSEM17-115 at University of Miami
11 déc. 2017 09h43 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BSEM” or “Company”), in collaboration with the University of Miami’s Department of Dermatology and...
BioStem Technologies, Inc. Announces the Addition of University of Miami Professor Brant D. Watson, Ph.D., to the Company’s Scientific Advisory Board
01 déc. 2017 15h05 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Dec. 01, 2017 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...